Skip to main content
VKTX logo
VKTX
(NASDAQ)
Viking Therapeutics, Inc.
$34.81-- (--)
Loading... - Market loading

Viking Therapeutics (VKTX) Stock Price & Financial Analysis

Viking Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$30.16 - $31.60
52-Week High$43.15
52-Week Low$22.96
Open$30.49
Volume3.39M
Average Volume (3M)1.95M
Market Cap3.51B
Shares Outstanding115.57M
Price to Book (P/B)7.00
EV/EBITDA-6.76
50-Day MA$31.50
200-Day MA$32.41
52-Week Change15.60%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Viking Therapeutics

What is the current stock price for VKTX?

As of the latest trading session, VKTX stock trades at $30.38. The 52-week range is $22.96–$43.15, with a day range of $30.16–$31.60.

What is the P/E ratio for VKTX?

The P/E ratio (Price-to-Earnings) for VKTX is shown in the Key Statistics section. This valuation metric helps compare Viking Therapeutics, Inc. to industry peers.

Does VKTX pay dividends?

Viking Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for VKTX?

Based on 8 analysts, the consensus for VKTX is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of VKTX?

Viking Therapeutics's market capitalization is $3.51B, classifying it as a mid-cap company. Viking Therapeutics operates in the Healthcare sector within the Biotechnology industry.